|Last Price$12.59||Day Change (%)0.48%|
|Open Price$12.59||Day Change ($)0.06|
|Day Range12.59–12.59||52-Week Range12.12–12.59|
As of Fri 06/24/2016 | USD
Sources Say Fresenius May Acquire Pfizer Medical Devices Arm for About $1.5 Billion
Global Infusion Pumps Market Analysis & Trends to 2025 - Increasing Demand for Infusion Therapy Is Favouring the Market Growth - Research and Markets
Canada Generic Drug Market 2016 - Industry Trends, Competitive Landscape, Opportunities and Outlook for the World's 9th Biggest Market - Research and Markets
Global Intravenous Solutions Market Growth of 5.79% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: Baxter, Terumo, Omnicare - Research and Markets
Despite the high 39% premium to Hospira's stock price, we believe the acquisition price is justified based on Pfizer's ability to unlock more value with its global reach.
Welcome to Hospira's First Quarter 2014 Conference Call. All lines have been placed on listen-only mode to prevent any background noise. Following the speakers' remarks, there will be a question-and-answer period.
Four candidates stood out from their growth counterparts.